AACR Award Targets Younger Ca Researchers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 10
Volume 4
Issue 10

PHILADELPHIA-The American Association for Cancer Research (AACR) is sponsoring its fourth annual Gertrude Elion Cancer Research Award. This award, provided through an educational grant from Glaxo Wellcome Oncology, is open to nontenured cancer investigators in clinical, basic, or translational research in the United States and Canada.

PHILADELPHIA-The American Association for Cancer Research (AACR)is sponsoring its fourth annual Gertrude Elion Cancer ResearchAward. This award, provided through an educational grant fromGlaxo Wellcome Oncology, is open to nontenured cancer investigatorsin clinical, basic, or translational research in the United Statesand Canada.

The application deadline is February 15, 1996, and the award willbe presented at the AACR annual meeting in Washington, DC, inApril, 1996.

The award recipient must have completed postdoctoral studies orclinical fellowships no later than July 1, 1996, and ordinarilynot more than 5 years prior to the award year. The 1-year awardincludes a $30,000 grant plus travel to the AACR annual meeting.

For more information, contact Jenny Anne Horst-Martz at the AACRin Philadelphia. Phone: 215-440-9300; Email: aacr@aol.com.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.